483Mar 6, 2023
483 Document: Reveragen Biopharma Inc.


On Mar 06, 2023, the FDA inspected Reveragen Biopharma Inc.'s Rockville site. Explore the inspectional observations.


On Mar 06, 2023, the FDA inspected Reveragen Biopharma Inc.'s Rockville site. Explore the inspectional observations.